Navera Investment Management Ltd. Has $289.05 Million Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Navera Investment Management Ltd. raised its stake in Intuitive Surgical by 0.1%, now owning 531,818 shares, valued at approximately $289 million.
• Intuitive Surgical reported a quarterly earnings per share of $2.19, surpassing estimates, with revenue at $2.44 billion, marking a year-over-year increase of 21.4%.
• Research analysts maintain a Moderate Buy rating for Intuitive Surgical, with an average target price of $589.43 following recent evaluations by several firms.

Navera Investment Management Ltd. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 531,818 shares of the medical equipment provider's stock after purchasing an additional 593 shares during the quarter. Intuitive Surgical comprises about 5.3% of Navera Investment Management Ltd.'s investment portfolio, making the stock its 7th largest holding. Navera Investment Management Ltd. owned about 0.15% of Intuitive Surgical worth $289,052,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical in the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical in the first quarter valued at about $30,000. TD Capital Management LLC increased its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical in the first quarter valued at about $30,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $440.94 on Wednesday. The company has a market cap of $158.07 billion, a PE ratio of 61.50, a PEG ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a 50-day simple moving average of $461.55 and a 200 day simple moving average of $499.41.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the company earned $1.78 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on ISRG. Truist Financial upped their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Piper Sandler restated an "overweight" rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI lowered their price target on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating for the company in a report on Tuesday. UBS Group increased their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $589.43.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.